Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ELI LILLY AND COMPANY v. ZYDUS PHARMACEUTICALS USA, INC.
Case Number:
2:11-cv-02582
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 09, 2012
Lilly, Zydus Settle ADHD Generic Infringement Case
Eli Lilly & Co. on Friday ended its New Jersey federal court suit against Zydus Pharmaceuticals USA Inc. as the companies reached an agreement resolving Eli Lilly's claims that the generics maker infringed its patented attention deficit hyperactivity disorder drug.
-
May 09, 2011
Lilly Claims Zydus Broke Deal In Strattera Row
Eli Lilly & Co. slapped Zydus Pharmaceuticals USA Inc. with a patent infringement suit Thursday in New Jersey, accusing it of breaching a consent order entered in a previous case Lilly brought over attention deficit hyperactivity disorder treatment Strattera.